Anti-Inflammatory Effects of Angiotensin Receptor Blockers in the Brain and the Periphery
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
In addition to regulating blood pressure, Angiotensin II (Ang II) exerts powerful pro-inflammatory effects in hypertension through stimulation of its AT1 receptors, most clearly demonstrated in peripheral arteries and in the cerebral vasculature. Administration of Ang II receptor blockers (ARBs) decreases hypertension-related vascular inflammation in peripheral organs. In rodent models of genetic hypertension, ARBs reverse the inflammation in the cerebral microcirculation. We hypothesized that ARBs could be effective in inflammatory conditions beyond hypertension. Our more recent studies, summarized here, indicate that this is indeed the case. We used the model of systemic administration of the bacterial endotoxin lipopolysaccharide (LPS). LPS produces a robust initial inflammatory reaction, the innate immune response, in peripheral organs and in the brain. Pretreatment with the ARB candesartan significantly diminishes the response to LPS, including reduction of pro-inflammatory cytokine release to the general circulation and decreased production and release of the pro-inflammatory adrenal hormone aldosterone. In addition, the ARB very significantly decreased the LPS-induced gene expression of pro-inflammatory cytokines and microglia activation in the brain. Our results demonstrate that AT1 receptor activity is essential for the unrestricted development of full-scale innate immune response in the periphery and in the brain. ARBs, due to their immune response-limiting properties, may be considered as therapeutically useful in a number of inflammatory diseases of the peripheral organs and the brain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration
Qin, L., Wu, X., Block, M. L., Liu, Y., Breese, G. R., Hong, J., Knapp, D. J., & Crews, F. T. (2007) · Glia · doi:10.1002/glia.20467 · Cited by 2,144 · cited 2×
“We reproduced the well-characterized and widespread central inflammatory response to LPS ( Qin et al. 2007; Quan et al. 1997, 1999, 2003; Singh and Jiang 2004), demonstrating a major increase in the gene expression of multiple pro-inflammatory factors including TNF-a, IL-1b, iNOS, ICAM-1, and vascular cell adhesion mo…”
BackgroundAngiotensin II cell signaling: physiological and pathological effects in the cardiovascular system
Mehta, P. K., & Griendling, K. K. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00287.2006 · Cited by 1,924 · cited 2×
“Most of the evidence for the central anti-inflammatory effects of the ARBs points to a focal interaction among the LPS, cytokine, aldosterone, and Ang II AT1 receptors pathways (Konsman et al. 2002; Lemarie ´ et al. 2008; Mehta and Griendling 2007 ).”
BackgroundStreit, W. J., Walter, S. A., & Pennell, N. A. (1999) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00069-0 · Cited by 1,096 · cited 1×
“We completed our experiments with an examination of the effects of LPS and ARB pretreatment on brain microglia, the central resident immune cells (Streit et al. 1999) and a major target for LPS in the brain (Lehnardt et al. 2003).”
MethodLehnardt, S., Massillon, L., Follett, P., Jensen, F. E., Ratan, R., Rosenberg, P. A., Volpe, J. J., & Vartanian, T. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1432609100 · Cited by 1,052
Cytokine-induced sickness behaviour: mechanisms and implications
Konsman, J. P., Parnet, P., & Dantzer, R. (2002) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)02088-9 · Cited by 999 · cited 4×
“The exact routes of communication between the brain and the immune system have been extensively studied but are not yet completely understood (Konsman et al. 2002; Quan and Banks 2007; Rivest 2003; Singh and Jiang 2004).”
BackgroundInfluentialBrain-immune communication pathways
Quan, N., & Banks, W. A. (2007) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2007.05.005 · Cited by 626 · cited 10×
“The exact routes of communication between the brain and the immune system have been extensively studied but are not yet completely understood (Konsman et al. 2002; Quan and Banks 2007; Rivest 2003; Singh and Jiang 2004).”
BackgroundMethodInfluentialHenry, C. J., Huang, Y., Wynne, A. M., & Godbout, J. P. (2009) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2008.09.002 · Cited by 565 · cited 1×
“In agreement with previous reports (Garden and Moller 2006; Henry et al. 2008), we found significant microglia activation by LPS in the brain cortex (Fig.”
ResultLAFLAMME, N., & RIVEST, S. (2001) · The FASEB Journal · doi:10.1096/fj.00-0339com · Cited by 501 · cited 2×
“…barrier is very poor or non-existent (Singh and Jiang 2004), and the endotoxin activates the brain innate immune response through stimulation of LPS receptors located in the circumventricular organs (Laflamme and Rivest 2001) and in the cerebrovascular endothelial cells (Xia et al. 2006).”
BackgroundRole of the renin–angiotensin system in vascular inflammation
Marchesi, C., Paradis, P., & Schiffrin, E. L. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.05.003 · Cited by 432 · cited 2×
“It has also been shown that in addition to reducing vasoconstriction, ARBs exert powerful anti-inflammatory effects in the peripheral vasculature (Marchesi et al. 2008).”
BackgroundSavoia, C., & Schiffrin, E. L. (2007) · Clinical Science · doi:10.1042/cs20060247 · Cited by 326 · cited 2×
“Of prime importance is the proinflammatory effect of Ang II in the peripheral vasculature in hypertension (Cheng et al. 2005; Sanz-Rosa et al. 2005; Suzuki et al. 2003), because inflammation is now recognized as a major factor in the development and maintenance of this disease ( Savoia and Schiffrin 2006, 2007 ).”
BackgroundThe LPS receptor (CD14) links innate immunity with Alzheimer's disease
Fassbender, K., Walter, S., Kühl, S., Landmann, R., Ishii, K., Bertsch, T., Stalder, A. K., Muehlhauser, F., Liu, Y., Ulmer, A. J., et al. (2004) · The FASEB Journal · doi:10.1096/fj.03-0364fje · Cited by 307 · cited 2×
“Chronic brain inflammation has been linked to the development of a number of neuro-psychiatric diseases including depression, Parkinson's and Alzheimer's diseases (Dutta et al. 2008; Fassbender et al. 2004; Rogers et al. 2007).”
BackgroundRogers, J., Mastroeni, D., Leonard, B., Joyce, J., & Grover, A. (2007) · International Review of Neurobiology · doi:10.1016/s0074-7742(07)82012-5 · Cited by 260
Quan, N., Stern, E. L., Whiteside, M. B., & Herkenham, M. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00193-3 · Cited by 251 · cited 2×
“We reproduced the well-characterized and widespread central inflammatory response to LPS (Qin et al. 2007; Quan et al. 1997, 1999, 2003; Singh and Jiang 2004), demonstrating a major increase in the gene expression of multiple pro-inflammatory factors including TNF-a, IL-1b, iNOS, ICAM-1, and…”
BackgroundThe lipopolysaccharide Parkinson’s disease animal model: mechanistic studies and drug discovery
Dutta, G., Zhang, P., & Liu, B. (2008) · Fundamental & Clinical Pharmacology · doi:10.1111/j.1472-8206.2008.00616.x · Cited by 235 · cited 2×
“Chronic brain inflammation has been linked to the development of a number of neuro- psychiatric diseases including depression, Parkinson’s and Alzheimer’s diseases (Dutta et al. 2008; Fassbender et al. 2004; Rogers et al. 2007).”
BackgroundGlucocorticoids Play a Fundamental Role in Protecting the Brain during Innate Immune Response
Nadeau, S., & Rivest, S. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-13-05536.2003 · Cited by 190
Ching, S., Zhang, H., Belevych, N., He, L., Lai, W., Pu, X.-A., Jaeger, L. B., Chen, Q., & Quan, N. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3357-07.2007 · Cited by 156
Armando, I., Carranza, A., Nishimura, Y., Hoe, K.-L., Barontini, M., Terrón, J. A., Falcón-Neri, A., Ito, T., Juorio, A. V., & Saavedra, J. M. (2001) · Endocrinology · doi:10.1210/endo.142.9.8366 · Cited by 148 · cited 6×
“We have previously reported that sustained treatment with the peripherally administered ARB candesartan, not only reversed the cerebrovascular inflammation in SHR, but also prevented the stress-induced HPA axis activation and the central sympathetic stimulation (Armando et al. 2001; Bregonzio et al. 2008; Saavedra et…”
BackgroundInfluentialSelf-citationArmando, I., Volpi, S., Aguilera, G., & Saavedra, J. M. (2007) · Brain Research · doi:10.1016/j.brainres.2007.01.037 · Cited by 86
Self-citation
Cited by
ACE2, angiotensin‐(1‐7) and Mas receptor axis in inflammation and fibrosis
Simões e Silva, A., Silveira, K., Ferreira, A., & Teixeira, M. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12159 · Cited by 542
The neuroinflammatory hypothesis of delirium
Cerejeira, J., Firmino, H., Vaz-Serra, A., & Mukaetova-Ladinska, E. B. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0674-1 · Cited by 472
Biancardi, V. C., Son, S. J., Ahmadi, S., Filosa, J. A., & Stern, J. E. (2014) · Hypertension · doi:10.1161/hypertensionaha.113.01743 · Cited by 270
Angiotensin II AT1 Receptor Blockade Ameliorates Brain Inflammation
Benicky, J., Sánchez-Lemus, E., Honda, M., Pang, T., Orecna, M., Wang, J., Leng, Y., Chuang, D.-M., & Saavedra, J. M. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2010.225 · Cited by 254
Self-citationSaavedra, J. M., Sánchez-Lemus, E., & Benicky, J. (2011) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2010.10.001 · Cited by 260
Self-citation
Metadata
- Authors
- Benicky, J., Sánchez-Lemus, E., Pavel, J., & Saavedra, J. M.
- Venue
- Cellular and Molecular Neurobiology
- Published
- 2009-03-04
- Volume
- 29
- Issue
- 6-7
- Pages
- 781-792
- ISSN
- 0272-4340 (ISSN-L)
- 1573-6830
- OpenAlex
- W2059864514
- Cited by
- 126
- References
- 18
- FWCI
- 5.14
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.